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Understanding 
Product Life Cycle 
    Define position within the Product Life Cycle 
 Each stage has Barrier Gate to the next level 
 Each Gate exponentially transforms complexity 
from Technical issues to Commercial 
 Time to Market is limited and may collapse 
 Market Entry Gate is most volatile and where the 
“Valley of Death” is most prominent 
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Process Scale-up 
Nanotechnology researchers skill set quickly becomes tested as 










Nano-PM provides needed expertise in material science, process expansion, 
regulatory compliance, facility scoping, budgeting, and schedules. 
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 Applications of the Nanomaterial 
 Identify End Products 
 Define Customers 
 Technical Competition,   
 both nano and current technology. 
 Size of current market, market growth 
and useful life (obsolescence) 
 Unit Sale Price vs. Cost to Produce – 




• Short term 
• Medium term 
• Long term 
Understanding 
Markets and Products  
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Understanding 






• Position in Product Life Cycle 
• Market and Product 
• Readiness Scoring 
Allows transition to next 
step- Information Gathering 
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Information 
Production Equipment - Lab to Plant 
Scale-up of Equipment 
• Full Equipment Set Defined 
• Throughput and Reliability 
• Costs and Options 
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Identify Grams to Tons Requirement 
   The “One to a Million” 
Early Equipment Validation Trials 
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Information 
Toxicity and EHS Testing 
• Extensive product Testing  
• Safety of Product during production 
• Safety of Product for Use 
• Long Term Impact on Health 
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• Global Governmental Regulations  
• International Standards for Nano 
• Transportation Restrictions 
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Information 
Testing and Pilot 
Pending Informational Issues found- 
• Run Equipment Pilots for Scale-up with 
Equipment Vendors 
• Mitigation methods test for EHS issues 
• Trial runs of products 
• Pilot test of governmental approval 








Plan for Testing of Risks 
Pilot Production  
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Information 
Gathering Data for Informed Decisions 
11 
Information Gathering on: 
• Production Equipment 
• Toxicity and EHS 
• Governmental Regulations 
• Testing and Pilots 
Allows transition to next step: 
Implementation of a Clear Strategy and  
Program Execution Plan 
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Implementation 
developing a Program Execution Plan  
 Program Execution Plan 
 Executive Summary 
 Program Description 
 Technology 
 Product Positioning 
 Life of product and obsolescence 
 Usage and commercial viability 
 Geographic positioning of market 
 Geographic optimization of manufacturing 
 Phasing Plan and Schedules 
 Financing, Budgets and Costing 




 Administration and Governance 
 Operations 
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Implementation 
Insurers & Risk Management 
Alignment of Risk Stakeholders 
 Information stage collected data focused 
on Insurer requirements 
 Questionnaire for Readiness focuses on key 
risk and insurance issues 
 Product manufacturing EHS risks – captured by 
NanoTox and toxicity testing 
 Long term Liabilities focused on end products 
 Insurance Partners included in plan 
 Risk Management  
Program Execution Planning  
 Captures all risk elements and how either 
insured or mitigated 
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Alignment of Financial Stakeholders 
 Information stage collected data focused 
on investor risk issues. 
 Questionnaire for Readiness defines areas of 
potential market revenue, costs, viability 
 Information stage develops equipment cost, 
detail capital needs, phasing of budgets  
 Business Model and projections 
 Investment Partners included in plan 
 Banks, Venture Capital, Funding 
Program Execution Planning  
 Captures financial model for budgets, cash 
flow, sources of funding, financial controls 
and governance 
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Implementation 
Governments and Logistics 
15 
Alignment of External Stakeholders 
 Information stage collected data focused 
on external positive or negative influences. 
 Questionnaire for Readiness outlines 
geographic areas, governmental and 
community support and or regulations 
 Information stage develops detail of regulatory 
environment and risks to product development 
 Information stage outlines community, supplier, 
or customer support or resistance 
 Governmental issues and Logistics 
Providers included in plan 
Program Execution Planning  
 Captures influence in various sections of 
Risk, Financing, Schedule restraints, etc. 
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Checkpoint: 
Change and Flexibility in Planning 
Technology and Innovation Fact: 
Constant Change in Conditions- 
Plans can be outdated immediately! 
Establish: 
 Lessons Learned at each step 
 Change Management 
 Know when you are changing 
 Know when to stop changing 
 Know when change is necessary 
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Questions      
Process Steps for Commercialization  
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Following the Steps: 
• Understanding 
• Information Gathering 
• Implementation Planning 
 Allows small steps and clear investment of 
resources to get to the next level 
 Reduces risks in each step 
 Challenges Plans based on data 
 Includes Stakeholders in Final Plan 
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Dan Bassett   Colorado   DanBassett@Nano-PM.com   
Bob Predmore    Arizona    BobPredmore@Nano-PM.com 
Harry Bushong  Texas    hbushong@nanotox.com 
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Preliminary Business Risk Matrix  
    Technology  
Review 
    Estimate (s)   
Development 
   Risk Matrix & 
 Business Plan 
 
 Capital Cost Estimate 
 Life Cycle 
 Raw Materials 
 Engineering 
 Labor Study 
 Priced Equipment List 
 Materials Takeoff/ 
Pricing 
 Site General Conditions 
 Range Estimating 
 Estimate Reviews 
 Sales Price 
 Capacity Requirements 
 Net Present Worth 
 Depreciation 
 Internal Rate of Return 
 Working Capital 
 
 Value engineering (2) 
 PSM support 
 Debottlenecking 
Issues 
 Hazard analysis 
 SHE issues 
 Constructability (2) 
 Cost benefit analysis 
 Time to Market 
 Phasing Plans 
 ROI Analysis 
 
 
Facility & Ops 
Questionnaire 
 
 Production Equipment 
Layout plot plans 
 Major Manufacturing 
Equipment 
 Design Criteria 
 Life Safety Analysis 
 Specialized HVAC 
Systems 
 Building Architecture  












 Submit Questionnaire 
 Strategic dates 
 Master project schedule 
Develop WBS 
 Production startup 
schedule  
 Team  Coordination 
(Responsibility Matrix) 
 Owner supplied info 
 Location  
 Black box equipment 
info 
 Code studies/permits 
 SHE status 
 Product Validity 
 Site visits 
 Initial Funding 
 
 Status of Lab Studies 
 Rate Controlling Steps 
 Life Safety Analysis 
 Scale up Studies  
 Product Stability 
 Product Uniformity 
 Raw Material Quality 
 Process Modeling 
 Turndown Ratio 
 Nameplate Capacity 
 Number of Trains 
 Storage of Product 
 Storage of Raw 
Materials 
 Environmental  
 Design Criteria 
 
 
Our proposed initial step is to conduct a questionnaire matrix to determine the 
Technical and Business readiness to assist new Nano scale-up planning  
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Concept Facility       
Planning 
3.0 
Front End Design 
4.0 





 Business Need 
 Project Sponsor 
 Steering Team 
 Project Charter 
 Sales Forecast 
 Sourcing Alternatives 
 Target Site 
 Technology Alternatives & 
Assessments 
 Legal & Environmental 
 Concept Designs Options 
 Operate & Maintain 
 Milestone Schedule 
 ROM estimate (+/-50%) 
 ROI Analysis 
 Economic Evaluation of 
Alternatives 
 Final Site Selection 
 Conceptual Design Scope 
Including Flow Sheets 
 Preliminary Project 
Execution Plan 
 VAR–Value Added Record 
 Risk Analysis 
 Resource Commitments 
 Readiness Review 
 Master Schedule 
 Conceptual Estimate (+/-
30%) 
 Project Design Basis 
 Project Execution Plan 
 Validation Master Plan 
 Long Lead Equipment 
Order Placement 
 Frozen Scope Document 
 Facility Acceptance 
Criteria 
 Risk Assessments 
 Project Review 
 Peer Review 
 3rd Party estimate Review 
 Project Baseline Schedule 
 CR Estimate (+/-10%) 
1 2 3 
Decision  








Gate Reject or 
Recycle 
Approve 
Initial Capital Request  ► Supplemental request  ► Full Funding Request   ► 
On completion of the Risk Matrix the focus will be to provide services for: 
Business(1.0) & Facility Plan (2.0) then Owner’s Representation for (3.0-5.0)     
 Stability Tests 
 Performance 
 Benchmark 
 Certification or 
Accreditation 
 Project Close-out 
 Share Lessons Learned 







Turn over to Operations 4 5 
Decision  
Gate Reject or 
Recycle 
 Environmental / 
Construction Permits 
 Implement Project 
Controls to baselines 
 Execution Contract 
Awards 
 Completed Engineering 
Work Packages 
 Completed Construction 
& Equipment Install 
 Construction & 
Equipment  
 Start-Up and 
Commissioning 
 Owner Operations Move-
In 
Approve 
Design  / Build     ► 
MAJOR DELIVERABLES 
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Owners Rep Scope of Project Services 
    Design 
4.0 
    Construction 
4.0 
  Operations & 
       Maintenance 5.0 
 Feasibility studies 
 Evaluation of alternatives 
 Conceptual cost estimating 
 Technology development  
 Technology scale-up 
 Process simplification 
 Project economic analysis 
 Site selection 
 Environmental assessments 
 PSM permitting–HAZOPS 
 Dynamic simulation analysis 
 Process engineering design 
 Detailed engineering 
 Equipment design 
 Facilities design 
 Instrumentation / Automation 
 Systems integration 
 CADD 
 Reliability analysis 
 Value engineering 
 Constructability reviews 
 Operability studies / manuals 
 Environmental and 
permitting assistance 
 Safety management 
 Planning and scheduling 
 Constructability 
 Labor relations/hiring 
 Community relations 
 Craft training 
 On-site materials 
management 
 Site security 
 Productivity management 
 Quality assurance 
 Field engineering 
 Prefabricate/Modularize 
 Mechanical integrity–PSM 
 Construction support 
facilities 
 Facility turnover/ 
commissioning 
 Plant operations 
 Maintenance/modifications 
 Facilities management 
 Operations training/start-up 
support 
 Predicative maintenance 
 PSM support 
 Contract maintenance 
 Warehouse management 




 Asbestos/lead abatement 
 Non destructive testing 
 Shutdown/outage planning 
 Environmental assessment 
 Environmental permitting 
assistance  
 Asset retirement  
 
    Procurement 
4.0 
 Global sourcing 
 Shop evaluations 
 Requisitioning/bid 
conditioning 
 Contracts negotiations 
 Vendor surveillance 
 Logistics 
 Expediting 
 Quality assurance 
 Vendor document control 
 Warranty/service 
management 








 Master project schedule 
 Process flow diagrams 
 Utility summary 
 Utility flow diagrams 
 Waste handling requirements 
 Interlock classifications and 
descriptions 
 Instrument list 
 Piping requirements 
 Special fittings list 
 Building & site requirements 
 Equipment arrangements 
and plot plans 
 Power distribution plan 
 Area electrical classification 
 Process descriptions 
 Detailed process control 
descriptions 
 Process control hardware 
description 
 Control system functional 
description 
Project Oversight is needed in the downstream execution steps as the 
Nanomaterial supplier & Nanomaterial purchaser move forward 
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• Relational analysis 
• Probability of  
   Occurrence (RP) 
• Impact of  





























Our Risk Management Process to Identify, Quantify, Strategize and Minimize 
 Risks, starts early and is continuous along  the entire project lifecycle 
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drop down lists, please select other and place a short answer in the text 
block provided. 
1. Name of the Person Completing this Survey  
 
(Provide two responses.) 
 
2. Street Address  
 
[          ]  
 
3. Country or Region of Your Research or Business  
 
(Select all that apply.) 
 
[ ]Abu Dhabi  
 
[ ]Albania  
 
[ ]Andora  
 
[ ]Argentina  
 
  
32. 1.12.4 Uptime Factor - Identify potential causes of downtime and 
there frequency i.e. cleaning equipment, maintenance, etc  
 
33. 1.12.5 Technology Alternatives - Define list of alternative 
technologies explored in the development process  
 
34. 1.12.6 Ide tify Strategic Dates - Identify the key dates to get 
product developed and to market  
 
35. 1.13 Product Specifics - Define the chemical name, and chemical 
makeup of the product  
 
36. 1.13.1 Product Stability - What is the product shelf life  
 
37. 1.13.2 Product Sales Price - Define the estimated sales price in $/lb 
or similar currency  
 
38. 1.13.3 Product Raw Materials Cost - Identify all known aspects of 





Sub Question: Raw Material #2 Select Unit of Weight Measure in 
this window. It will then skip to where the quantity or actual 
we gh  should be enter d.  
 
( )grams (Skip to Q. 286)  
 
( )kilograms (Skip to Q. 286)  
 
( )ounce (Skip to Q. 286)  
 
( )lbs (Skip to Q. 286)  
 
( )tonne (Skip to Q. 286)  
 
( )ton (us) (Skip to Q. 286)  
 
286. 
Sub Question: Raw Material #2 According to Weight Measure 
Selected in Prior Window  
 
[          ]  
 
287. 
If you plan on multiple product lines what Percentages of 
Production volume for each planned industrial function of the 
Nanomaterial. Product Line #1  
 
( )Product Line #1 (Skip to Q. 288)  
 
288. 
Product Line #1 Percentage (Combined selections shall equal 
100%)  
 




Are procedures communicated to customers in order to inform 
them on how to safely use, dispose of, or recycle the product 
and manage environmental, health, and safety risks?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
408. 
Do labels and other safety-information communications indicate 
the extent of harm that could result from reasonably 
foreseeable misuse?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
409. 
Does packaging comply with transportation and risk 
regulations? Are workers and customers throughout the 
lifecycle adequately informed and protected?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
410. Is the environment protected from the identified hazards?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
411. Are warnings (if applicable) available throughout the product 
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This new tool allows you to search the U.S. state by state to locate nanotechnology-related facilities,  
